Please assess the completion status of the following clinical trial:

Trial Title: Preventing Violence Among Veterans in Substance Use Disorder Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Participants with severe and recent violence (i.e., injuring another person in the past year) will be eligible for the RCT.~* Eligible patients also will meet DSM-IV criteria for either alcohol or illicit drug (e.g., cocaine, marijuana, opiates, etc.) abuse/dependence.~* The study will include those with comorbid mood and/or anxiety problems (e.g., depression, PTSD and other anxiety disorders), whether or not on medication at the point of recruitment, with the exception of those who have schizophrenia and/or are mentally incompetent (e.g., unable to provide informed consent).~* A brief mental status screen will with an established cutoff will be required for competency.~Exclusion Criteria:~* Participants who are suicidal (ideation, intent and plan) at the point of recruitment will not be enrolled in the study. Rather, research staff will inform clinical staff at the study site if a potential participant is currently suicidal.~* Participants who report transient suicidal ideation but no intent or plan will be eligible to participate.~* As noted, individuals with schizophrenia and/or who are mentally incompetent to consent for participation will be excluded. Finally, participants who live outside the study catchment area (i.e., a 45 mile radius of the VA Ann Arbor Healthcare System) will be excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1: MI-CBT (Type: EXPERIMENTAL): MI-CBT (six sessions during acute treatment phase integrating motivational interviewing and cognitive behavioral approaches)
- Arm 2: MI-CBT+CC (Type: EXPERIMENTAL): MI-CBT+CC (acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention)
- Arm 3: E-TAU (Type: ACTIVE_COMPARATOR): E-TAU (enhanced treatment as usual - includes brief session and provision of resources)

Based on this trial design, predict the completion outcome and termination type (if applicable).